Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

COMy 2020

Therapy Updates

View all
5:33
The importance of tailored treatment approach in multiple myeloma
Paul Richardson • 18 Oct 2020
3:24
The impact of CHIP expression on multiple myeloma treatment
Irene Ghobrial • 1 Oct 2020
1:30
Treatment approaches for fit and frail multiple myeloma patients
Jesús San Miguel • 8 Oct 2020
5:11
New developments in maintenance therapy for multiple myeloma
Graham Jackson • 2 Oct 2020

Immuno-Oncology

View all
4:52
CD38: a promising target for multiple myeloma antibody therapy
Saad Usmani • 5 Oct 2020
5:15
Promising clinical trials for multiple myeloma: KarMMa, CARTITUDE and EVOLVE
Noopur Raje • 21 Sep 2020

MRD Updates

View all
2:51
Profiling deep minimal residual disease in multiple myeloma
Bruno Paiva • 23 Sep 2020
1:46
The assets of MRD in myeloma
Bruno Paiva • 23 Sep 2020

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals